Ovarian Cancer Support – A New Program for Women Battling Cancer

Written By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

Ovarian Cancer Support – A New Program for Women Battling Cancer

New York City’s Mount Sinai Hospital recognizes that women experiencing an ovarian cancer diagnosis need ovarian cancer support because it can be an isolating and scary diagnosis.

In response, the hospital created the Woman to Woman program to provide one-to-one peer mentoring and support to patients who are fighting gynecologic cancers – from those who have been through it.

ovarian cancer support a new program for women battling cancer

“A person who can provide the best support to someone who is newly diagnosed is someone who has been in that seat,” said Rachel Justus, licensed clinical social worker and program coordinator for Woman to Woman.

Patients are given support in whatever way they choose, from email and phone interactions to having someone accompany them to chemotherapy treatment sessions.

Ovarian cancer is the deadliest form of reproductive cancer:

  • About 22,280 women each year receive a new ovarian cancer diagnosis.
  • A woman’s risk of getting ovarian cancer is about one in 75, and her lifetime chance of dying from the disease is one in 100.
  • Approximately 75 percent of women with ovarian cancer have stage 3 or 4 of the disease.
  • The five-year survival rate for stage 3 and 4 ovarian cancer ranges from 17 to 39 percent, according to the American Cancer Society.
  • Medical evidence suggests that women who use talcum powder for feminine hygiene have a greater risk of developing ovarian cancer.

Thousands of women across the nation have filed suit against Johnson & Johnson for failing to warn consumers of the possible link between ovarian cancer and the company’s baby powder.

Two of those lawsuits have resulted in a finding of liability and damage orders:

  • In February 2016, a jury ordered J&J to pay $72 million to the family of a woman who died from ovarian cancer in October 2015.
  • On May 1, a jury ordered J&J to pay $55 million to a South Dakota woman who survived ovarian cancer.

Both women used the company’s talc-based powders in their genital areas.

A recent study from Brigham and Women’s Hospital in Boston has found that women who regularly used talc in their genital area, sanitary napkins, tampons, and underwear had a 33 percent higher risk of developing ovarian cancer.

Table of Contents
Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources